Omada Health

NASDAQ:OMDA

Medical - Healthcare Information Services

Healthcare
$13.17 +0.78%

+$0.13 today

Market cap
$817.04M
Beta
2.09
P/E (TTM)
-162.6
EPS (TTM)
-$0.11
52W Low $10.28High $26.92

Volume 1.68M

Average 1.07M

OMDA Common Stock Issued

Cash raised by issuing new shares.

Omada HealthNASDAQ: OMDA

Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026

Common stock issued grows, but more slowly than its trailing trend

Q1 FY2026 common stock issued of $3.25M rose 253.3% year over year, behind the +4286.9% change in trailing-twelve-month common stock issued. Sequentially, it fell 3.8% from the prior quarter. Over 3 fiscal years it compounded at +360.7% a year.

Context

  • Common stock issued amounted to 65.3% of revenue in FY2025, up 63.3 pp from a year earlier.
  • Common stock issued increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +253.3% toward the trailing-twelve-month pace of +4286.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.25M-3.8% QoQ
Last fiscal yearDec 2025
$169.9M+5003.6% YoY
LTMMar 2026
$172.23M+4286.9% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+253.3%——
1 year+5003.6%——
3-year CAGR+360.7%——
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
169.9M USD
Year-over-year change
+5003.6%
3-year CAGR
+360.7%

Common Stock Issued vs competitors

How OMDA compares with its peers on the latest reported figures

  • OMDA's LTM Mar 2026 common stock issued of $172.23M is the largest of the 5 companies compared; the peer median is $9.97M.
  • Its year-over-year change of +4286.9% is the 2nd highest of 5, against a peer median of +81.4%.
  • Common stock issued amounts to 60.8% of revenue for OMDA, versus a peer median of 0.5%.
OMDA Competitors Peer median
Common Stock Issued for OMDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OMDAOmada HealthLTM Mar 2026$172.23M +4286.9%+360.7%60.8%
HIMSHims & Hers Health, Inc.LTM Sep 2026$21.84M +19.3%—0.8%
HNGEHinge Health, Inc.LTM Jun 2026$17.23M +10735.8%—2.4%
TDOCTeladoc Health, Inc.LTM Mar 2026$2.72M -63.5%-37.1%0.1%
AMWLAmerican Well CorporationLTM Mar 2026$603K +143.6%—0.3%
Peer median (excluding OMDA) $9.97M+81.4%-37.1%0.5%

Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(72.52M)(67.51M)(47.14M)(12.78M)
Depreciation & Amortization4.33M4.45M4.8M5.49M
Deferred Income Tax0000
Stock-Based Compensation6.65M8.74M9.42M12.96M
Change in Working Capital(9.15M)(1.5M)(6.57M)3.74M
Accounts Receivables(3.93M)(5.34M)(8.81M)(12.36M)
Inventory(1.95M)(74K)318K(1.19M)
Accounts Payables(4.99M)(286K)399K6.29M
Other Working Capital1.73M4.2M1.52M11M
Other Non-Cash Items1.7M6.09M5.3M8.85M
Operating Cash Flow(68.98M)(49.74M)(34.18M)18.25M
Capital Expenditures(2.72M)(2.92M)(3.86M)(1.32M)
Acquisitions (Net)0000
Purchases of Investments0000
Sales of Investments0000
Other Investing Activities(2M)(2.51M)(3.27M)(4.51M)
Investing Cash Flow(2.72M)(2.92M)(3.86M)(5.83M)
Debt Repayment(1.27M)963K0(30.96M)
Common Stock Issued1.74M1.76M3.33M169.9M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities1.27M(2.54M)(4.54M)(5.71M)
Financing Cash Flow16.32M179K(1.21M)133.22M
Effect of Forex Changes0000
Net Change in Cash(55.38M)(52.48M)(39.25M)145.64M
Free Cash Flow(71.7M)(52.66M)(38.04M)16.93M

Omada Health

NASDAQ:OMDA

Intrinsic Alpha fair value

Locked

Current Price

$13.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.